These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27544585)

  • 1. Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.
    Sumner RP; Ren H; Ferguson BJ; Smith GL
    Vaccine; 2016 Sep; 34(40):4827-34. PubMed ID: 27544585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy.
    Sumner RP; Ren H; Smith GL
    J Gen Virol; 2013 May; 94(Pt 5):1121-1126. PubMed ID: 23288427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.
    García-Arriaza J; Gómez CE; Sorzano CÓ; Esteban M
    J Virol; 2014 Mar; 88(6):3392-410. PubMed ID: 24390336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy.
    Clark RH; Kenyon JC; Bartlett NW; Tscharke DC; Smith GL
    J Gen Virol; 2006 Jan; 87(Pt 1):29-38. PubMed ID: 16361415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
    Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
    J Virol; 2019 May; 93(10):. PubMed ID: 30814284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
    Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD
    Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
    Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the
    Bravo Cruz AG; Han A; Roy EJ; Guzmán AB; Miller RJ; Driskell EA; O'Brien WD; Shisler JL
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the effects of insertion of a 5.2 kb region of a VACV genome, which contains known immune evasion genes, on MVA immunogenicity.
    Ryerson MR; Shisler JL
    Virus Res; 2018 Feb; 246():55-64. PubMed ID: 29341877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor.
    Ren H; Ferguson BJ; Maluquer de Motes C; Sumner RP; Harman LE; Smith GL
    Immunology; 2015 May; 145(1):34-49. PubMed ID: 25382035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination.
    Jentarra GM; Heck MC; Youn JW; Kibler K; Langland JO; Baskin CR; Ananieva O; Chang Y; Jacobs BL
    Vaccine; 2008 Jun; 26(23):2860-72. PubMed ID: 18455281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus.
    Mathew A; O'Bryan J; Marshall W; Kotwal GJ; Terajima M; Green S; Rothman AL; Ennis FA
    PLoS One; 2008 Oct; 3(10):e3323. PubMed ID: 18830408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.
    Braxton CL; Puckett SH; Mizel SB; Lyles DS
    J Virol; 2010 Apr; 84(7):3552-61. PubMed ID: 20089648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strikingly poor CD8+ T-cell immunogenicity of vaccinia virus strain MVA in BALB/c mice.
    Russell TA; Tscharke DC
    Immunol Cell Biol; 2014; 92(5):466-9. PubMed ID: 24566805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.
    Staib C; Kisling S; Erfle V; Sutter G
    J Gen Virol; 2005 Jul; 86(Pt 7):1997-2006. PubMed ID: 15958679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
    Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
    Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
    Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
    Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments
    de Freitas LFD; Oliveira RP; Miranda MCG; Rocha RP; Barbosa-Stancioli EF; Faria AMC; da Fonseca FG
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.